SCHEMBL39766

SCHEMBL39766

C[C@@H]1CN(c2nc3c(-c4ccc(C5C=CC=CC5)nc4)cnn3c3c2C(=O)CCN3)C[C@H](C)O1

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 2/20 0.31
PIK3CD O00329 1/20 0.30
PIK3CA P42336 1/20 0.30
PIK3CB P42338 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30450 0.83 ALDH1A1 (0.37) PIK3CA
SCHEMBL10210944 0.69 MAPK1 (0.38) PIK3CDPIK3CA
SCHEMBL15026251 0.69 NPC1 (0.40)
SCHEMBL39794 0.67 WNT3A (0.37)
SCHEMBL10211443 0.66 MTOR (0.35) PIK3CDPIK3CA
SCHEMBL10234775 0.65 NPC1 (0.45)
SCHEMBL15026288 0.64 PARP10 (0.35) NTRK1PIK3CA
SCHEMBL30716 0.61 MTOR (0.43)
SCHEMBL15026255 0.61 MTOR (0.43)
SCHEMBL2725224 0.61 ADORA2A (0.42) PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012027234-A1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN SCHERING CORPORATION (US) 2012-03-01 WO disclosed